cefixime has been researched along with Sensitivity and Specificity in 10 studies
Cefixime: A third-generation cephalosporin antibiotic that is stable to hydrolysis by beta-lactamases.
cefixime : A third-generation cephalosporin antibiotic bearing vinyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is used in the treatment of gonorrhoea, tonsilitis, pharyngitis, bronchitis, and urinary tract infections.
Sensitivity and Specificity: Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| " The method herein described was successfully applied for the evaluation of pharmacokinetic profiles of cefixime capsule in 24 healthy volunteers." | 1.33 | Sensitive liquid chromatography-tandem mass spectrometry method for the determination of cefixime in human plasma: application to a pharmacokinetic study. ( Chen, X; Meng, F; Zeng, Y; Zhong, D, 2005) |
| "Cefixime was kept for patients not responding to the first GU treatment." | 1.31 | Cost-effectiveness of management strategies for acute urethritis in the developing world. ( Crabbé, F; de Clerck, M; Laga, M; Vuylsteke, B, 2000) |
| " The method was found to be reproducible and convenient for quantitative analysis of ceftriaxone, cefixime and cefotaxime in their raw materials and their dosage forms." | 1.30 | HPTLC determination of ceftriaxone, cefixime and cefotaxime in dosage forms. ( Agbaba, D; Eric-Jovanovic, S; Vladimirov, S; Zivanov-Stakic, D, 1998) |
| "We studied the action of nifedipine on the bioavailability of cefixime, a molecule absorbed via the gut wall dipeptide carrier system in the rat, and on the bioavailability of D-xylose, which is absorbed via a pH (and Na(+)-)-dependent transporter." | 1.28 | Modification of cefixime bioavailability by nifedipine in humans: involvement of the dipeptide carrier system. ( Bouten, A; Carbon, C; Deslandes, A; Duverne, C; Farinotti, R; Trouvin, JH; Westphal, JF, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yola, ML | 1 |
| Eren, T | 1 |
| Atar, N | 1 |
| Pisarev, VV | 1 |
| Zaĭtseva, KV | 1 |
| Smirnova, LB | 1 |
| Belolipetskaia, VG | 1 |
| Kibal'chich, DA | 1 |
| Koltunov, IE | 1 |
| Balashov, S | 1 |
| Mordechai, E | 1 |
| Adelson, ME | 1 |
| Gygax, SE | 1 |
| Foster, G | 1 |
| Hopkins, GF | 1 |
| Gunn, GJ | 1 |
| Ternent, HE | 1 |
| Thomson-Carter, F | 1 |
| Knight, HI | 1 |
| Graham, DJ | 1 |
| Edge, V | 1 |
| Synge, BA | 1 |
| Meng, F | 1 |
| Chen, X | 1 |
| Zeng, Y | 1 |
| Zhong, D | 1 |
| Eric-Jovanovic, S | 1 |
| Agbaba, D | 1 |
| Zivanov-Stakic, D | 1 |
| Vladimirov, S | 1 |
| Crabbé, F | 1 |
| Vuylsteke, B | 1 |
| de Clerck, M | 1 |
| Laga, M | 1 |
| Weagant, SD | 1 |
| Bound, AJ | 1 |
| Chiba, N | 1 |
| Rao, BV | 1 |
| Rademaker, JW | 1 |
| Hunt, RH | 1 |
| Duverne, C | 1 |
| Bouten, A | 1 |
| Deslandes, A | 1 |
| Westphal, JF | 1 |
| Trouvin, JH | 1 |
| Farinotti, R | 1 |
| Carbon, C | 1 |
1 review available for cefixime and Sensitivity and Specificity
| Article | Year |
|---|---|
Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Cefixime; Cefotaxime; Drug Therapy, Combination; Helico | 1992 |
9 other studies available for cefixime and Sensitivity and Specificity
| Article | Year |
|---|---|
Molecularly imprinted electrochemical biosensor based on Fe@Au nanoparticles involved in 2-aminoethanethiol functionalized multi-walled carbon nanotubes for sensitive determination of cefexime in human plasma.
Topics: Biosensing Techniques; Cefixime; Conductometry; Cysteamine; Electrodes; Equipment Design; Equipment | 2014 |
[Determination of cefixime blood plasma levels by HPLC].
Topics: Administration, Oral; Anti-Bacterial Agents; Capsules; Cefixime; Chromatography, High Pressure Liqui | 2009 |
Multiplex bead suspension array for screening Neisseria gonorrhoeae antibiotic resistance genetic determinants in noncultured clinical samples.
Topics: Alleles; Anti-Infective Agents; Azithromycin; Cefixime; Cephalosporins; Chromosomes, Bacterial; Cipr | 2013 |
A comparison of two pre-enrichment media prior to immunomagnetic separation for the isolation of E. coli O157 from bovine faeces.
Topics: Animals; Anti-Bacterial Agents; Bacteriological Techniques; Bacteriophage Typing; Cattle; Cefixime; | 2003 |
Sensitive liquid chromatography-tandem mass spectrometry method for the determination of cefixime in human plasma: application to a pharmacokinetic study.
Topics: Anti-Bacterial Agents; Area Under Curve; Cefixime; Chromatography, Liquid; Humans; Male; Reference S | 2005 |
HPTLC determination of ceftriaxone, cefixime and cefotaxime in dosage forms.
Topics: Cefixime; Cefotaxime; Ceftriaxone; Cephalosporins; Chromatography, High Pressure Liquid; Dosage Form | 1998 |
Cost-effectiveness of management strategies for acute urethritis in the developing world.
Topics: Acute Disease; Anti-Bacterial Agents; Anti-Infective Agents; Cefixime; Cost-Benefit Analysis; Decisi | 2000 |
Evaluation of techniques for enrichment and isolation of Escherichia coli O157:H7 from artificially contaminated sprouts.
Topics: Agar; Cefixime; Colony Count, Microbial; Culture Media; Escherichia coli O157; Germination; Immunoma | 2001 |
Modification of cefixime bioavailability by nifedipine in humans: involvement of the dipeptide carrier system.
Topics: Administration, Oral; Adult; Biological Availability; Biological Transport, Active; Cefixime; Cefota | 1992 |